Sucrose esters with various hydrophilic–lipophilic properties: Novel controlled release agents for oral drug delivery matrix tablets prepared by direct compaction
Source abstract
Abstract
Sucrose esters (SE) are esters of sucrose and fatty acids with various hydrophilic-lipophilic properties which have attracted interest from being used in pharmaceutical applications. This study aimed to gain insight into the use of SE as controlled release agents for direct compacted matrix tablets. The study focused on the effect of hydrophilic-lipophilic properties on tableting properties and drug release. Sucrose stearate with hydrophilic-lipophilic balance (HLB) values ranging from 0 to 16 was systematically tested. Tablet formulations contained SE, metoprolol tartrate as a highly soluble model drug and dibasic calcium phosphate dihydrate as a tablet formulation filler in the ratio 1:1:2. The compaction behaviour of matrix tablets was compared with the compacts of individual starting materials as reference. SE incorporation improved the plasticity, compressibility and lubricating property of powder mixtures. The hydrophilic-lipophilic properties of SE affected tableting properties, drug release rate and release mechanism. Increasing hydrophilicity corresponding to the increased monoesters in SE composition increased the relative porosity, elastic recovery and tensile strength of the tablets due to the increased hydrogen bonding between the monoesters. This also facilitated the swelling behaviour of SE, which sustained the drug release rate. A sustained release effect prevailed in tablets containing SE with HLB values of 3-16. The ability to improve the tableting properties as well as sustain the drug release rate of the highly soluble model drug via gelation of SE highlights SE as promising controlled release regulators for direct compacted matrix tablets comprising drugs with various solubilities according to the Biopharmaceutics Classification System.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Drug Solubulity and Delivery Systems · Advanced Drug Delivery Systems · Pharmaceutical studies and practices
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (46)
Show source-provided references
1. Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance10.1016/S1461-5347(00)00269-8 ↗
2. Mitsubishi-Kagaku Foods Corporation. Ryoto® Sugar Ester Technical Information. Tokyo: Mitsubishi-Kagaku Foods Corporation; 2003.
3. Sucrose ester microemulsions10.1016/S0167-7322(99)80010-5 ↗
4. Winsor behaviour of sucrose fatty acid esters: choice of the cosurfactant and effect of the surfactant composition10.1016/S0927-7757(01)01067-6 ↗
5. Studies on the metabolic fate of sucrose esters in rats10.1016/0278-6915(84)90321-1 ↗
6. Metabolism of 14C-labelled sucrose esters of stearic acid in rats10.1016/S0278-6915(97)00012-4 ↗
7. Food applications of sucrose esters
8. Comparison of foaming and interfacial properties of pure sucrose monolaurates, dilaurate and commercial preparations10.1016/S0268-005X(98)00036-8 ↗
9. Effect of surfactant sucrose ester on physical properties of dairy whipped emulsions in relation to those of O/W interfacial layers10.1016/j.jcis.2005.09.010 ↗
10. Enhancement of dissolution rate of nifedipine using sucrose ester coprecipitates10.1016/0378-5173(93)90179-J ↗
11. Effect of sugar ester and hydroxypropyl methylcellulose on the physicochemical stability of amorphous cefditoren pivoxil in aqueous suspension10.1016/j.ijpharm.2004.11.020 ↗
12. Ex vivo oral mucosal permeation of lidocaine hydrochloride with sucrose fatty acid esters as absorption enhancers10.1016/S0378-5173(98)00226-9 ↗
13. Sucrose cocoate, a component of cosmetic preparations, enhances nasal and ocular peptide absorption10.1016/S0378-5173(02)00597-5 ↗
14. Application of sucrose fatty acid esters in transdermal therapeutic systems10.1016/j.ejpb.2006.07.009 ↗
15. Novel transdermal delivery of timolol maleate using sugar esters: Preclinical and clinical studies10.1016/j.ejpb.2008.12.003 ↗
16. Microcrystalline cellulose-sucrose esters as tablet matrix forming agents10.1016/0378-5173(95)00021-A ↗
17. Development of novel fast-disintegrating tablets by direct compression using sucrose stearic acid ester as a disintegration-accelerating agent10.1248/cpb.56.1384 ↗
18. Glycerin fatty acid esters as a new lubrication of tablets10.1016/j.ijpharm.2004.12.007 ↗
19. The Merck Index: An encyclopedia of chemicals, drugs, and biological. 14th edition. NJ: Merck & Co., Inc.; 2006. p 6149.
20. Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995;12(3);413–420.10.1023/A:1016212804288 ↗
21. Elastic recovery and surface area changes in compacted powder systems10.1016/0032-5910(74)80054-9 ↗
22. Fell JT, Newton JM. Determination of tablet strength by diametral compression test. J Pharm Sci 1970;59(12);688–691.10.1002/jps.2600590523 ↗
23. An analysis of powder compaction phenomena
24. Modeling and comparison of dissolution profiles10.1016/S0928-0987(01)00095-1 ↗
25. Analysis of fickian and non-fickian release from polymers
26. Drug release from hydrocolloid embedding with high or low susceptibility to hydrodynamic stress10.1023/A:1016238427313 ↗
27. Tablet strength, porosity, elasticity and solid state structure of tablets compressed at high loads10.1016/0378-5173(95)04336-5 ↗
28. Densification properties and compactability of mixtures of pharmaceutical excipients with and without magnesium stearate10.1016/0378-5173(88)90076-2 ↗
29. Force–displacement and network measurement
30. Influence of the granulating method on bulk properties and tabletability of a high dosage drug10.1016/0378-5173(82)90116-8 ↗
31. An evaluation of the techniques employed to investigate powder compaction behaviour10.1016/0378-5173(82)90112-0 ↗
32. The use of energy indices in estimating powder compaction functionality of mixtures in pharmaceutical tableting10.1016/S0378-5173(98)00347-0 ↗
33. Characterisation of particle properties and compaction behaviour of hydroxypropyl methylcellulose with different degrees of methoxy/hydroxypropyl substitution10.1016/S0928-0987(99)00054-8 ↗
34. Stress relaxation of compacts produced from viscoelastic materials10.1016/S0378-5173(97)04889-8 ↗
35. Porosity expansion of tablets as a result of bonding and deformation of particulate solids10.1016/0378-5173(96)04584-X ↗
36. Consolidation and compaction of powder mixtures: II. Binary mixtures of different particle size fractions of α-lactose monohydrate10.1016/0378-5173(91)90338-O ↗
37. The effect of rate of force application on the properties of microcrystalline cellulose and dibasic calcium phosphate mixtures10.1016/0378-5173(91)90102-T ↗
38. Prediction of the compression behavior of powder mixtures by the Heckel equation10.1016/0378-5173(93)90022-8 ↗
39. Compaction behaviour and new predictive approach to the compressibility of binary mixtures of pharmaceutical excipients10.1016/j.ejpb.2006.03.004 ↗
40. Compression and compaction properties of plasticised high molecular weight hydroxypropylmethylcellulose (HPMC) as a hydrophilic matrix carrier10.1016/j.ijpharm.2005.12.025 ↗
41. Study of thermal behaviour of sugar esters10.1016/j.ijpharm.2006.11.053 ↗
42. A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs10.1016/0168-3659(87)90034-4 ↗
43. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices10.1016/0168-3659(87)90035-6 ↗
44. Simultaneous probing of swelling, erosion and dissolution by NMR-microimaging – effect of solubility of additives on HPMC matrix tablets10.1016/j.ejps.2009.01.008 ↗
45. Investigation of critical polymer properties for polymer release and swelling of HPMC matrix tablets10.1016/j.ejps.2008.10.021 ↗
46. The influence of substitution type on the performance of methylcellulose and hydroxypropylmethylcellulose in gels and matrices10.1016/0378-5173(93)90085-T ↗